EditorialDrug Development

Seeking Validation

See allHide authors and affiliations

Science Translational Medicine  30 May 2012:
Vol. 4, Issue 136, pp. 136ed5
DOI: 10.1126/scitranslmed.3004193

Article Information

vol. 4 no. 136 136ed5

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. David Roblin
  1. David Robbins is the Chief Medical Officer of Creabilis, a clinical stage European biotechnology company, and former Head of Pfizer’s Clinical R&D branch in Europe.

Altmetric

Article usage

Article usage: May 2012 to November 2019

AbstractFullPdf
May 2012038696
Jun 201205404181
Jul 20120233221
Aug 20120237416
Sep 201202133
Oct 2012097
Nov 2012023
Dec 20120108
Jan 2013024
Feb 20130114
Mar 20130211
Apr 20130115
May 20130222
Jun 20130321
Jul 20130170
Aug 20130170
Sep 20130241
Oct 20130233
Nov 2013090
Dec 20130121
Jan 20140221
Feb 20140212
Mar 20140121
Apr 20140150
May 20140170
Jun 20141130
Jul 20140180
Aug 20140100
Sep 20140123
Oct 2014010
Nov 2014010
Dec 2014033
Feb 2015001
Mar 2015010
Apr 2015011
May 2015011
Jun 2015011
Jul 2015010
Aug 2015020
Nov 2015002
Dec 2015011
Jan 2016001
Feb 2016011
Mar 2016020
Apr 2016001
May 2016020
Jun 2016020
Jul 2016041
Aug 2016040
Nov 2016022
Jan 2017030
Feb 2017040
Apr 2017010
May 2017021
Jun 2017010
Jul 2017041
Aug 2017010
Sep 2017020
Oct 2017030
Nov 2017020
Dec 2017020
Jan 2018021
Feb 2018020
Mar 2018020
Apr 2018060
Jun 2018030
Jul 2018020
Aug 2018020
Sep 2018022
Oct 2018031
Nov 2018010
Dec 2018030
Jan 2019010
Feb 2019050
Mar 2019020
Apr 2019020
May 2019030
Jun 2019020
Jul 2019010
Aug 2019030
Sep 2019030
Oct 2019040
Nov 2019001